Autosomal dominant polycystic kidney disease: an overview of recent genetic and clinical advances
Authors:
Open Access
- 23 April 2025
- journal article
- review article
- Published by Taylor & Francis in Renal Failure
- Vol. 47 (1) , 2492374
Abstract
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common inherited kidney disease, characterized by the progressive development of multiple kidney cysts, leading to a gradual decline in kidney function. ADPKD is also the fourth leading cause of kidney failure (KF) in adults. In addition to kidney manifestations, ADPKD is associated with various extrarenal features, including liver cysts, cardiovascular abnormalities, intracranial aneurysms, and chronic pain with significant impact on patients' quality of life. While several disease-modifying agents have been tested in ADPKD, tolvaptan remains the only approved drug by the US Food and Drug Administration. The Mayo Imaging Classification is currently the most practical tool for predicting rate of kidney disease progression in ADPKD. This review provides a comprehensive overview of ADPKD, focusing on its genetics, pathophysiology, clinical presentation, management, and prognostic tools. Advances in diagnostic imaging and genetic testing have improved the early detection of ADPKD, allowing better classification of patients and prediction of KF. The review also discusses current therapeutic approaches to ADPKD, including tolvaptan, a vasopressin V2-receptor antagonist. Additionally, we address specific issues in children and pregnant individuals with ADPKD. Despite substantial progress in understanding ADPKD, there is a large need for additional effective treatments and prognostic markers to provide a more personalized care for these patients.Keywords
This publication has 236 references indexed in Scilit:
- Identification of Patients With Autosomal Dominant Polycystic Kidney Disease at Highest Risk for End-Stage Renal DiseaseJournal of Urology, 1998
- The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitroKidney International, 1996
- Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease — a contiguous gene syndromeNature Genetics, 1994
- Pregnancy outcome and its relationship to progression of renal failure in autosomal dominant polycystic kidney disease.Journal of the American Society of Nephrology, 1994
- Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family membersKidney International, 1994
- Renal Stone Disease in Autosomal Dominant Polycystic Kidney DiseaseAmerican Journal of Kidney Diseases, 1993
- Autosomal Dominant Polycystic Kidney Disease—More Than a Renal DiseaseAmerican Journal of Kidney Diseases, 1990
- Indirect inguinal hernia in CAPD patients with polycystic kidney disease.1989
- Perforation of the Colon in Renal Homograft RecipientsAnnals of Surgery, 1986
- Perimesencephalic hemorrhageNeurology, 1985